Back to Newsroom

Alder BioPharmaceuticals Announces Third Quarter 2016 Financial and Operating Results

BOTHELL, Wash., Oct. 27, 2016 (GLOBE NEWSWIRE) — Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced its financial results for the third quarter ended Sept. 30, 2016, and provided a corporate and clinical update.

Click here to read the full release